-
DMD Cell Therapy Trial Put on Voluntary Hold
Capricor put a Phase 2 trial of its Duchenne cell therapy on hold pending a safety review, after a severe reaction in a patient, possibly due to treatment. Read more about this decision here.
Do you agree with Capricor’s decision? Are you concerned about this trial’s future?
Sorry, there were no replies found.
Log in to reply.